FdaApplication
BLA 761142
Identifiers
- fda_app_no: BLA761142
Properties
| Property | Value |
|---|---|
| applicant_name | Horizon Therapeutics Ireland DAC |
| application_type | BLA |
| approval_date | 2020-06-11 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| UPLIZNA | INEBILIZUMAB-CDON | 100MG/10ML (10MG/ML) | Injection |
1 product